Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Neoplasms 3Neoplasm Metastasis 3Melanoma 3Glioblastoma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Somatostatinoma 2Sarcoma 2Rectal Neoplasms 2Prostatic Neoplasms 2Neoplasms, Plasma Cell 2Multiple Myeloma 2Mesothelioma, Malignant 2Insulinoma 2Glucagonoma 2Gliosarcoma 2Gastrinoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Islet Cell 2Brain Neoplasms 2von Hippel-Lindau Disease 1Vipoma 1Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Solitary Fibrous Tumor, Pleural 1Primary Myelofibrosis 1Pheochromocytoma 1

Interventions

Ifosfamide 8Doxorubicin 8Radiotherapy 6Chemotherapy, Adjuvant 4Neoadjuvant Therapy 3Filgrastim 3Vincristine 2Trabectedin 2Etoposide 2Epirubicin 2Dactinomycin 2Cyclophosphamide 2Carboplatin 2vatalanib 1soblidotin 1romidepsin 1perifosine 1indolepropanol phosphate 1exatecan 1cixutumumab 1brostallicin 1Watchful Waiting 1Temozolomide 1Sunitinib 1Sorafenib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hemangiopericytoma, Malignant × vatalanib × Clear all
NCT00348790 2018-10-26

Vatalanib in Treating Patients With Recurrent or Progressive Meningioma

Northwestern University

Phase 2 Completed
25 enrolled 10 charts
CNSSarcoma

Hemangiopericytoma, Malignant, Brain Neoplasms, Meningioma, Sarcoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡